3.22.1 html 228 353 1 false 93 0 false 8 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.novabaypharma.com/20220331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.novabaypharma.com/20220331/role/statement-condensed-consolidated-balance-sheets-unaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://www.novabaypharma.com/20220331/role/statement-condensed-consolidated-balance-sheets-unaudited-parentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://www.novabaypharma.com/20220331/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Sheet http://www.novabaypharma.com/20220331/role/statement-condensed-consolidated-statements-of-stockholders-equity-deficit-unaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.novabaypharma.com/20220331/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Organization Sheet http://www.novabaypharma.com/20220331/role/statement-note-1-organization Note 1 - Organization Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Business Combination Sheet http://www.novabaypharma.com/20220331/role/statement-note-3-business-combination- Note 3 - Business Combination Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Fair Value Measurements Sheet http://www.novabaypharma.com/20220331/role/statement-note-4-fair-value-measurements Note 4 - Fair Value Measurements Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Prepaid Expenses and Other Current Assets Sheet http://www.novabaypharma.com/20220331/role/statement-note-5-prepaid-expenses-and-other-current-assets Note 5 - Prepaid Expenses and Other Current Assets Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Inventory Sheet http://www.novabaypharma.com/20220331/role/statement-note-6-inventory Note 6 - Inventory Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Property and Equipment Sheet http://www.novabaypharma.com/20220331/role/statement-note-7-property-and-equipment Note 7 - Property and Equipment Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Goodwill Sheet http://www.novabaypharma.com/20220331/role/statement-note-8-goodwill Note 8 - Goodwill Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Other Intangible Assets Sheet http://www.novabaypharma.com/20220331/role/statement-note-9-other-intangible-assets Note 9 - Other Intangible Assets Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Accrued Liabilities Sheet http://www.novabaypharma.com/20220331/role/statement-note-10-accrued-liabilities Note 10 - Accrued Liabilities Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Line of Credit Sheet http://www.novabaypharma.com/20220331/role/statement-note-11-line-of-credit Note 11 - Line of Credit Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Commitments and Contingencies Sheet http://www.novabaypharma.com/20220331/role/statement-note-12-commitments-and-contingencies Note 12 - Commitments and Contingencies Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Warrant Liability Sheet http://www.novabaypharma.com/20220331/role/statement-note-13-warrant-liability Note 13 - Warrant Liability Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Stockholders' Equity Sheet http://www.novabaypharma.com/20220331/role/statement-note-14-stockholders-equity Note 14 - Stockholders' Equity Notes 20 false false R21.htm 020 - Disclosure - Note 15 - Equity-based Compensation Sheet http://www.novabaypharma.com/20220331/role/statement-note-15-equitybased-compensation Note 15 - Equity-based Compensation Notes 21 false false R22.htm 021 - Disclosure - Note 16 - License, Collaboration and Distribution Agreements Sheet http://www.novabaypharma.com/20220331/role/statement-note-16-license-collaboration-and-distribution-agreements- Note 16 - License, Collaboration and Distribution Agreements Notes 22 false false R23.htm 022 - Disclosure - Note 17 - Employee Benefit Plan Sheet http://www.novabaypharma.com/20220331/role/statement-note-17-employee-benefit-plan Note 17 - Employee Benefit Plan Notes 23 false false R24.htm 023 - Disclosure - Note 18 - Related Party Transactions Sheet http://www.novabaypharma.com/20220331/role/statement-note-18-related-party-transactions Note 18 - Related Party Transactions Notes 24 false false R25.htm 024 - Disclosure - Note 19 - Paycheck Protection Program Sheet http://www.novabaypharma.com/20220331/role/statement-note-19-paycheck-protection-program Note 19 - Paycheck Protection Program Notes 25 false false R26.htm 025 - Disclosure - Note 20 - Segment Reporting Sheet http://www.novabaypharma.com/20220331/role/statement-note-20-segment-reporting Note 20 - Segment Reporting Notes 26 false false R27.htm 026 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.novabaypharma.com/20220331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies 27 false false R28.htm 027 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies 28 false false R29.htm 028 - Disclosure - Note 3 - Business Combination (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-3-business-combination-tables Note 3 - Business Combination (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-3-business-combination- 29 false false R30.htm 029 - Disclosure - Note 4 - Fair Value Measurements (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-4-fair-value-measurements-tables Note 4 - Fair Value Measurements (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-4-fair-value-measurements 30 false false R31.htm 030 - Disclosure - Note 5 - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-5-prepaid-expenses-and-other-current-assets-tables Note 5 - Prepaid Expenses and Other Current Assets (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-5-prepaid-expenses-and-other-current-assets 31 false false R32.htm 031 - Disclosure - Note 6 - Inventory (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-6-inventory-tables Note 6 - Inventory (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-6-inventory 32 false false R33.htm 032 - Disclosure - Note 7 - Property and Equipment (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-7-property-and-equipment-tables Note 7 - Property and Equipment (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-7-property-and-equipment 33 false false R34.htm 033 - Disclosure - Note 9 - Other Intangible Assets (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-9-other-intangible-assets-tables Note 9 - Other Intangible Assets (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-9-other-intangible-assets 34 false false R35.htm 034 - Disclosure - Note 10 - Accrued Liabilities (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-10-accrued-liabilities-tables Note 10 - Accrued Liabilities (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-10-accrued-liabilities 35 false false R36.htm 035 - Disclosure - Note 12 - Commitments and Contingencies (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-12-commitments-and-contingencies-tables Note 12 - Commitments and Contingencies (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-12-commitments-and-contingencies 36 false false R37.htm 036 - Disclosure - Note 13 - Warrant Liability (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-13-warrant-liability-tables Note 13 - Warrant Liability (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-13-warrant-liability 37 false false R38.htm 037 - Disclosure - Note 14 - Stockholders' Equity (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-14-stockholders-equity-tables Note 14 - Stockholders' Equity (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-14-stockholders-equity 38 false false R39.htm 038 - Disclosure - Note 15 - Equity-based Compensation (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-15-equitybased-compensation-tables Note 15 - Equity-based Compensation (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-15-equitybased-compensation 39 false false R40.htm 039 - Disclosure - Note 16 - License, Collaboration and Distribution Agreements (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-16-license-collaboration-and-distribution-agreements-tables Note 16 - License, Collaboration and Distribution Agreements (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-16-license-collaboration-and-distribution-agreements- 40 false false R41.htm 040 - Disclosure - Note 18 - Related Party Transactions (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-18-related-party-transactions-tables Note 18 - Related Party Transactions (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-18-related-party-transactions 41 false false R42.htm 041 - Disclosure - Note 20 - Segment Reporting (Tables) Sheet http://www.novabaypharma.com/20220331/role/statement-note-20-segment-reporting-tables Note 20 - Segment Reporting (Tables) Tables http://www.novabaypharma.com/20220331/role/statement-note-20-segment-reporting 42 false false R43.htm 042 - Disclosure - Note 1 - Organization (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-1-organization-details-textual Note 1 - Organization (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-1-organization 43 false false R44.htm 043 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies-tables 44 false false R45.htm 044 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents, and Restricted Cash (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies-components-of-cash-cash-equivalents-and-restricted-cash-details Note 2 - Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents, and Restricted Cash (Details) Details 45 false false R46.htm 045 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies-disaggregation-of-revenue-details Note 2 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) Details 46 false false R47.htm 046 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Revenues and Accounts Receivable From Major Distribution Partners and Customers (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies-revenues-and-accounts-receivable-from-major-distribution-partners-and-customers-details Note 2 - Summary of Significant Accounting Policies - Revenues and Accounts Receivable From Major Distribution Partners and Customers (Details) Details 47 false false R48.htm 047 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Goodwill and Intangible Assets (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies-goodwill-and-intangible-assets-details Note 2 - Summary of Significant Accounting Policies - Goodwill and Intangible Assets (Details) Details 48 false false R49.htm 048 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Calculation of Basic and Diluted EPS (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies-calculation-of-basic-and-diluted-eps-details Note 2 - Summary of Significant Accounting Policies - Calculation of Basic and Diluted EPS (Details) Details 49 false false R50.htm 049 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Outstanding Stock Options and Stock Warrants Excluded From the Diluted Net Loss Per Share Computation (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-2-summary-of-significant-accounting-policies-outstanding-stock-options-and-stock-warrants-excluded-from-the-diluted-net-loss-per-share-computation-details Note 2 - Summary of Significant Accounting Policies - Outstanding Stock Options and Stock Warrants Excluded From the Diluted Net Loss Per Share Computation (Details) Details 50 false false R51.htm 050 - Disclosure - Note 3 - Business Combination (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-3-business-combination-details-textual Note 3 - Business Combination (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-3-business-combination-tables 51 false false R52.htm 051 - Disclosure - Note 3 - Business Combination - Purchase Price Allocation of Estimated Fair Values of Identifiable Assets Acquired and Liabilities Assumed (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-3-business-combination-purchase-price-allocation-of-estimated-fair-values-of-identifiable-assets-acquired-and-liabilities-assumed-details Note 3 - Business Combination - Purchase Price Allocation of Estimated Fair Values of Identifiable Assets Acquired and Liabilities Assumed (Details) Details 52 false false R53.htm 052 - Disclosure - Note 3 - Business Combination - Fair Value of Identifiable Intangible Assets Acquired (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-3-business-combination-fair-value-of-identifiable-intangible-assets-acquired-details Note 3 - Business Combination - Fair Value of Identifiable Intangible Assets Acquired (Details) Details 53 false false R54.htm 053 - Disclosure - Note 4 - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-4-fair-value-measurements-assets-and-liabilities-measured-at-fair-value-on-a-recurring-basis-details Note 4 - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 54 false false R55.htm 054 - Disclosure - Note 4 - Fair Value Measurements - Fair Value of Warrant Liability (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-4-fair-value-measurements-fair-value-of-warrant-liability-details Note 4 - Fair Value Measurements - Fair Value of Warrant Liability (Details) Details 55 false false R56.htm 055 - Disclosure - Note 5 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-5-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details Note 5 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Details 56 false false R57.htm 056 - Disclosure - Note 6 - Inventory - Summary of Inventory (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-6-inventory-summary-of-inventory-details Note 6 - Inventory - Summary of Inventory (Details) Details 57 false false R58.htm 057 - Disclosure - Note 7 - Property and Equipment (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-7-property-and-equipment-details-textual Note 7 - Property and Equipment (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-7-property-and-equipment-tables 58 false false R59.htm 058 - Disclosure - Note 7 - Property and Equipment - Summary of Property and Equipment (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-7-property-and-equipment-summary-of-property-and-equipment-details Note 7 - Property and Equipment - Summary of Property and Equipment (Details) Details 59 false false R60.htm 059 - Disclosure - Note 8 - Goodwill (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-8-goodwill-details-textual Note 8 - Goodwill (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-8-goodwill 60 false false R61.htm 060 - Disclosure - Note 9 - Other Intangible Assets (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-9-other-intangible-assets-details-textual Note 9 - Other Intangible Assets (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-9-other-intangible-assets-tables 61 false false R62.htm 061 - Disclosure - Note 9 - Other Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-9-other-intangible-assets-schedule-of-finitelived-intangible-assets-details Note 9 - Other Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) Details 62 false false R63.htm 062 - Disclosure - Note 9 - Other Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-9-other-intangible-assets-schedule-of-finitelived-intangible-assets-future-amortization-expense-details Note 9 - Other Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Details 63 false false R64.htm 063 - Disclosure - Note 10 - Accrued Liabilities - Summary of Accrued Liabilities (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-10-accrued-liabilities-summary-of-accrued-liabilities-details Note 10 - Accrued Liabilities - Summary of Accrued Liabilities (Details) Details 64 false false R65.htm 064 - Disclosure - Note 11 - Line of Credit (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-11-line-of-credit-details-textual Note 11 - Line of Credit (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-11-line-of-credit 65 false false R66.htm 065 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-12-commitments-and-contingencies-details-textual Note 12 - Commitments and Contingencies (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-12-commitments-and-contingencies-tables 66 false false R67.htm 066 - Disclosure - Note 12 - Commitments and Contingencies - Lease Expense (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-12-commitments-and-contingencies-lease-expense-details Note 12 - Commitments and Contingencies - Lease Expense (Details) Details 67 false false R68.htm 067 - Disclosure - Note 12 - Commitments and Contingencies - Schedule of Future Lease Payments (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-12-commitments-and-contingencies-schedule-of-future-lease-payments-details Note 12 - Commitments and Contingencies - Schedule of Future Lease Payments (Details) Details 68 false false R69.htm 068 - Disclosure - Note 13 - Warrant Liability (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-13-warrant-liability-details-textual Note 13 - Warrant Liability (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-13-warrant-liability-tables 69 false false R70.htm 069 - Disclosure - Note 13 - Warrant Liability - The Key Assumptions Used to Value the Warrants (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-13-warrant-liability-the-key-assumptions-used-to-value-the-warrants-details Note 13 - Warrant Liability - The Key Assumptions Used to Value the Warrants (Details) Details 70 false false R71.htm 070 - Disclosure - Note 14 - Stockholders' Equity (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-14-stockholders-equity-details-textual Note 14 - Stockholders' Equity (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-14-stockholders-equity-tables 71 false false R72.htm 071 - Disclosure - Note 14 - Stockholders' Equity - Outstanding Warrants (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-14-stockholders-equity-outstanding-warrants-details Note 14 - Stockholders' Equity - Outstanding Warrants (Details) Details 72 false false R73.htm 072 - Disclosure - Note 15 - Equity-based Compensation (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-15-equitybased-compensation-details-textual Note 15 - Equity-based Compensation (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-15-equitybased-compensation-tables 73 false false R74.htm 073 - Disclosure - Note 15 - Equity-based Compensation - Stock Options Outstanding (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-15-equitybased-compensation-stock-options-outstanding-details Note 15 - Equity-based Compensation - Stock Options Outstanding (Details) Details 74 false false R75.htm 074 - Disclosure - Note 15 - Equity-based Compensation - Weighted-average Assumptions Used in Determining the Value of Options Granted to Employees and Directors (Details) Sheet http://www.novabaypharma.com/20220331/role/statement--note-15-equitybased-compensation-weightedaverage-assumptions-used-in-determining-the-value-of-options-granted-to-employees-and-directors-details Note 15 - Equity-based Compensation - Weighted-average Assumptions Used in Determining the Value of Options Granted to Employees and Directors (Details) Details 75 false false R76.htm 075 - Disclosure - Note 15 - Equity-based Compensation - Summary of Stock-based Compensation Expense Included in Results of Operations (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-15-equitybased-compensation-summary-of-stockbased-compensation-expense-included-in-results-of-operations-details Note 15 - Equity-based Compensation - Summary of Stock-based Compensation Expense Included in Results of Operations (Details) Details 76 false false R77.htm 076 - Disclosure - Note 16 - License, Collaboration and Distribution Agreements (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-16-license-collaboration-and-distribution-agreements-details-textual Note 16 - License, Collaboration and Distribution Agreements (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-16-license-collaboration-and-distribution-agreements-tables 77 false false R78.htm 077 - Disclosure - Note 16 - License, Collaboration and Distribution Agreements - Changes in Assets and Liabilities (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-16-license-collaboration-and-distribution-agreements-changes-in-assets-and-liabilities-details Note 16 - License, Collaboration and Distribution Agreements - Changes in Assets and Liabilities (Details) Details 78 false false R79.htm 078 - Disclosure - Note 16 - License, Collaboration and Distribution Agreements - Total Revenues (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-16-license-collaboration-and-distribution-agreements-total-revenues-details Note 16 - License, Collaboration and Distribution Agreements - Total Revenues (Details) Details 79 false false R80.htm 079 - Disclosure - Note 17 - Employee Benefit Plan (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-17-employee-benefit-plan-details-textual Note 17 - Employee Benefit Plan (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-17-employee-benefit-plan 80 false false R81.htm 080 - Disclosure - Note 18 - Related Party Transactions (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-18-related-party-transactions-details-textual Note 18 - Related Party Transactions (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-18-related-party-transactions-tables 81 false false R82.htm 081 - Disclosure - Note 18 - Related Party Transactions - Related Party Revenue, Cost of Goods Sold, and Expenses (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-18-related-party-transactions-related-party-revenue-cost-of-goods-sold-and-expenses-details Note 18 - Related Party Transactions - Related Party Revenue, Cost of Goods Sold, and Expenses (Details) Details 82 false false R83.htm 082 - Disclosure - Note 19 - Paycheck Protection Program (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-19-paycheck-protection-program-details-textual Note 19 - Paycheck Protection Program (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-19-paycheck-protection-program 83 false false R84.htm 083 - Disclosure - Note 20 - Segment Reporting (Details Textual) Sheet http://www.novabaypharma.com/20220331/role/statement-note-20-segment-reporting-details-textual Note 20 - Segment Reporting (Details Textual) Details http://www.novabaypharma.com/20220331/role/statement-note-20-segment-reporting-tables 84 false false R85.htm 084 - Disclosure - Note 20 - Segment Reporting - Financial Information by Segment (Details) Sheet http://www.novabaypharma.com/20220331/role/statement-note-20-segment-reporting-financial-information-by-segment-details Note 20 - Segment Reporting - Financial Information by Segment (Details) Details 85 false false All Reports Book All Reports nby20220331_10q.htm ex_369607.htm ex_369608.htm ex_369609.htm ex_369610.htm nby-20220331.xsd nby-20220331_cal.xml nby-20220331_def.xml nby-20220331_lab.xml nby-20220331_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true